Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
This phase II trial will compare the efficacy and toxicity of the combination of Irinotecan
and Oxaliplatin versus 5-FU/LV and Oxaliplatin as first line treatment in patients with
locally advanced or metastatic gastric cancer